Input-specific regulation of glutamatergic synaptic transmission in the medial prefrontal cortex by mGlu


Journal

Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400

Informations de publication

Date de publication:
06 04 2021
Historique:
entrez: 7 4 2021
pubmed: 8 4 2021
medline: 14 1 2022
Statut: epublish

Résumé

Metabotropic glutamate receptors (mGluRs) are G protein-coupled receptors that regulate various aspects of central nervous system processing in normal physiology and in disease. They are thought to function as disulfide-linked homodimers, but studies have suggested that mGluRs can form functional heterodimers in cell lines. Using selective allosteric ligands, ex vivo brain slice electrophysiology, and optogenetic approaches, we found that two mGluR subtypes-mGluR2 and mGluR4 (or mGlu

Identifiants

pubmed: 33824180
pii: 14/677/eabd2319
doi: 10.1126/scisignal.abd2319
pmc: PMC8279257
mid: NIHMS1714035
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS031373
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS113614
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103537
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH108498
Pays : United States
Organisme : NINDS NIH HHS
ID : R37 NS031373
Pays : United States

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Nat Neurosci. 2009 Jul;12(7):939-45
pubmed: 19503087
Nat Commun. 2017 Dec 6;8(1):1967
pubmed: 29213077
Nat Neurosci. 2015 Nov;18(11):1687-1697
pubmed: 26457553
J Comp Neurol. 1991 Nov 22;313(4):574-86
pubmed: 1783682
J Comp Neurol. 1977 Jan 15;171(2):157-91
pubmed: 64477
Expert Opin Ther Pat. 2015 Jan;25(1):69-90
pubmed: 25435285
PLoS Biol. 2005 Dec;3(12):e402
pubmed: 16279838
FASEB J. 2011 Jan;25(1):66-77
pubmed: 20826542
Brain Res. 1991 Dec 6;566(1-2):26-39
pubmed: 1726062
J Neurosci. 2014 Jan 1;34(1):79-94
pubmed: 24381270
Schizophr Bull. 2014 Mar;40 Suppl 2:S107-16
pubmed: 24375459
J Pharmacol Exp Ther. 2014 Sep;350(3):495-505
pubmed: 24947466
Annu Rev Pharmacol Toxicol. 1997;37:205-37
pubmed: 9131252
J Comp Neurol. 1995 Oct 2;360(4):555-70
pubmed: 8801249
Nat Neurosci. 2012 Dec;15(12):1736-41
pubmed: 23143517
Elife. 2017 Jun 29;6:
pubmed: 28661401
Neuropharmacology. 2011 Jun;60(7-8):1017-41
pubmed: 21036182
ACS Chem Neurosci. 2018 Sep 19;9(9):2188-2204
pubmed: 29792024
Neuron. 2016 Oct 5;92(1):143-159
pubmed: 27641494
Trends Cogn Sci. 2018 Nov;22(11):1011-1025
pubmed: 30236489
ACS Chem Neurosci. 2016 Sep 21;7(9):1201-11
pubmed: 27441572
Trends Neurosci. 2015 Mar;38(3):158-66
pubmed: 25583269
J Pharmacol Exp Ther. 2007 Jan;320(1):437-47
pubmed: 17021259
J Pharmacol Exp Ther. 2012 Feb;340(2):404-21
pubmed: 22088953
Neuropsychopharmacology. 2015 Mar 13;40(5):1250-8
pubmed: 25413183
Hippocampus. 2000;10(4):411-9
pubmed: 10985280
Eur J Pharmacol. 2010 Aug 10;639(1-3):81-90
pubmed: 20371229
Annu Rev Pharmacol Toxicol. 2010;50:295-322
pubmed: 20055706
Brain Res. 1996 May 13;720(1-2):211-9
pubmed: 8782914
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1196-201
pubmed: 25583490
Pharmacol Rev. 2009 Dec;61(4):395-412
pubmed: 19926678
Neuropsychopharmacology. 2011 Jan;36(2):529-38
pubmed: 20962768
Neurosci Lett. 1996 Jan 5;202(3):197-200
pubmed: 8848265
Science. 2017 Jul 14;357(6347):162-168
pubmed: 28706064
J Pharmacol Exp Ther. 2000 Jan;292(1):76-87
pubmed: 10604933
FASEB J. 2012 Apr;26(4):1682-93
pubmed: 22223752
Mol Pharmacol. 2018 May;93(5):526-540
pubmed: 29545267
Br J Pharmacol. 2013 Aug;169(8):1824-39
pubmed: 23714045
Neuron. 2016 Feb 17;89(4):857-66
pubmed: 26853301
Neuroscience. 1993 Apr;53(4):1009-18
pubmed: 8389425
J Comp Neurol. 1977 Apr 15;172(4):687-722
pubmed: 838895
Mol Pharmacol. 2008 Nov;74(5):1345-58
pubmed: 18664603
Neurosci Biobehav Rev. 2012 Jan;36(1):134-42
pubmed: 21605592
Front Syst Neurosci. 2013 Aug 09;7:37
pubmed: 23950738
Nature. 2010 Jun 10;465(7299):788-92
pubmed: 20473285
Brain Res. 2008 Mar 4;1197:47-62
pubmed: 18242587
Neurobiol Dis. 2014 Jan;61:55-71
pubmed: 24076101
Prog Neurobiol. 2015 Nov;134:178-201
pubmed: 26408506
Nature. 2000 Oct 26;407(6807):971-7
pubmed: 11069170
Mol Pharmacol. 2007 Aug;72(2):477-84
pubmed: 17526600
Mol Pharmacol. 2008 Apr;73(4):1213-24
pubmed: 18171729
Biol Psychiatry. 2018 Apr 15;83(8):648-656
pubmed: 29275841
Neuropharmacology. 2001 Mar;40(3):311-8
pubmed: 11166323
Neuropharmacology. 1995 Jan;34(1):1-26
pubmed: 7623957
Mol Pharmacol. 2012 Sep;82(3):438-47
pubmed: 22653971
Nat Chem Biol. 2011 Jul 24;7(9):624-30
pubmed: 21785426
J Comp Neurol. 1987 Aug 1;262(1):46-58
pubmed: 3624548
Neuroscience. 2001;105(2):379-92
pubmed: 11672605
Curr Top Behav Neurosci. 2018;36:107-135
pubmed: 28831734
Neuropharmacology. 2017 Mar 15;115:149-165
pubmed: 27465045
J Biol Chem. 1996 Nov 8;271(45):28612-6
pubmed: 8910492

Auteurs

Zixiu Xiang (Z)

Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, USA.

Xiaohui Lv (X)

Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, USA.

Xin Lin (X)

Department of Psychiatry, Columbia University, New York, NY 10032, USA.
Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.

Daniel E O'Brien (DE)

Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, USA.

Molly K Altman (MK)

Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, USA.

Craig W Lindsley (CW)

Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, USA.
Department of Chemistry, Vanderbilt University, Nashville, TN 37232, USA.

Jonathan A Javitch (JA)

Department of Psychiatry, Columbia University, New York, NY 10032, USA.
Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.
Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY 10032, USA.

Colleen M Niswender (CM)

Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, USA.
Vanderbilt Kennedy Center, Vanderbilt University, Nashville, TN 37232, USA.

P Jeffrey Conn (PJ)

Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA. jeff.conn@vanderbilt.edu.
Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, USA.
Vanderbilt Kennedy Center, Vanderbilt University, Nashville, TN 37232, USA.

Articles similaires

1.00
Animals Mice Immunity, Innate Interneurons Synapses
Animals Entorhinal Cortex Interneurons Parvalbumins Mice
Humans Female Prefrontal Cortex Male Spectroscopy, Near-Infrared
Humans Parkinson Disease Proteomics Single-Cell Analysis Brain

Classifications MeSH